Operating Lease, Right-of-Use Asset of Adicet Bio, Inc. from 01 Jan 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adicet Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2020 to 30 Sep 2025.
  • Adicet Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $11,901,000, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,901,000 -$3,149,000 -21% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $12,555,000 -$3,300,000 -21% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $13,383,000 -$3,264,000 -20% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $14,228,000 -$3,196,000 -18% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $15,050,000 -$3,135,000 -17% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $15,855,000 -$3,078,000 -16% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $16,647,000 -$3,061,000 -16% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $17,424,000 -$2,845,000 -14% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $18,185,000 -$2,806,000 -13% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $18,933,000 -$2,465,000 -12% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $19,708,000 -$5,000 -0.02% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $20,269,000 -$89,000 -0.44% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $20,991,000 +$126,000 +0.6% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $21,398,000 -$291,000 -1.3% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $19,713,000 -$2,667,000 -12% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $20,358,000 -$2,708,000 -12% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $20,865,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $21,689,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $22,380,000 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $23,066,000 +$21,666,000 +1548% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $1,400,000 01 Jan 2020 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.